ICD-10 code E29.8: Other testicular dysfunction

Key Takeaways

E29.8 (Other testicular dysfunction) is a billable, male-specific ICD-10-CM code valid for reimbursement claims with dates of service on or after October 1, 2015.

Mullerian inhibiting factor deficiency is the primary clinical synonym documented under E29.8, covering testicular dysfunctions not captured by E29.0 or E29.1.

Klinefelter syndrome (Q98.0, Q98.1, Q98.4) is excluded via an Excludes1 note, meaning it cannot be coded alongside E29.8 on the same claim.

Pabau’s claims management software helps endocrinology and men’s health practices submit E29.8 claims accurately and reduce preventable denials.

ICD-10 code E29.8 is a billable, male-specific ICD-10-CM code for “Other testicular dysfunction” — testicular endocrine disorders that do not meet the criteria for testicular hyperfunction (E29.0) or hypofunction (E29.1). Its primary clinical synonym is Mullerian inhibiting factor deficiency.

This guide covers the billable status, clinical synonyms, Excludes1 notes, MS-DRG grouping, and documentation requirements for E29.8, with practical guidance on choosing between E29.8, E29.1, and E29.9.

Providers managing male endocrine conditions across men’s health practice software platforms need structured coding workflows to avoid the most common E29.8 pitfalls: Applying Excludes1 rules correctly, and selecting the most specific code rather than defaulting to E29.9 (Unspecified) when specific documentation exists. The sections below address each of these systematically.

ICD-10 code E29.8: Clinical definition and billable status

ICD-10 code E29.8 is a billable, specific diagnosis code that represents “Other testicular dysfunction,” classified within the ICD-10-CM section E20-E35 (Disorders of other endocrine glands), part of the endocrine, nutritional and metabolic diseases chapter (E00-E89). According to CMS ICD-10-CM guidelines, this code has been valid and reimbursable for claims with dates of service on or after October 1, 2015, and remains active through FY2026.

The code sits within the E29 category (Testicular dysfunction), which itself is a non-billable parent code. Payers require a specific child code such as E29.8 for claim adjudication. E29 alone will result in rejection.

E29.8 carries a male-only diagnosis flag. Submitting this code on a claim for a female patient will trigger an automatic sex-edit denial. All payers using HIPAA-mandated ICD-10-CM transactions enforce this restriction.

Synonyms and clinical conditions included under E29.8

The primary ICD-10-CM synonym documented under E29.8 is Mullerian inhibiting factor deficiency. This is a rare endocrine condition in which the testes fail to produce adequate anti-Mullerian hormone (AMH), resulting in persistence of Mullerian duct structures in genetically male patients. E29.8 functions as a residual category for testicular dysfunctions that do not meet the criteria for E29.0 (Testicular hyperfunction) or E29.1 (Testicular hypofunction).

Clinically, E29.8 may apply to:

• Mullerian inhibiting factor (MIF) deficiency (Persistent Mullerian duct syndrome)
• Other specified disorders of testicular hormone secretion not classified as hyperfunction or hypofunction
• Testicular endocrine dysfunction with documented laboratory abnormalities where neither E29.0 nor E29.1 captures the full clinical picture
• Disorders of testicular differentiation not attributed to chromosomal abnormalities (which would require Q codes)

Providers treating patients at HRT and hormone therapy practices should review clinical documentation carefully before selecting E29.8, since overlapping testosterone findings may better fit E29.1 (Testicular hypofunction) when low testosterone is the primary, documented diagnosis. In those cases, treatment such as a testosterone cypionate injection is billed separately from the diagnosis code.

ICD-10 code E29.8 vs. E29.1 vs. E29.9: Which code applies?

Choosing the wrong code within the E29 category is the most common documentation error for this code family. Here is how the three codes differ in practice.

The practical rule: If a patient has documented low testosterone with a clear primary diagnosis of hypogonadism, E29.1 captures the condition more specifically. E29.8 applies when the clinical evidence points to a testicular endocrine disorder that falls outside those defined categories.

E29.9 should only appear when the documentation genuinely does not support a more specific code, and auditors treat frequent use of E29.9 as a documentation quality flag.

Structured clinical record management helps providers distinguish these categories consistently. When patient records include testosterone lab values, AMH levels, and clinical impression notes in a single view, coders can select the most specific code without chasing documentation across multiple systems.

Reduce claim denials for endocrine and men’s health codes

Pabau's claims management tools help providers submit E29.8 and related diagnostic codes with the documentation support needed to clear payer edits on first submission.

Book a demo

Excludes notes and coding restrictions for ICD-10 code E29.8

The Excludes1 note attached to the E29 category is one of the most consequential coding rules for this code family. Excludes1 means the listed conditions are mutually exclusive with E29.8 and cannot appear on the same claim.

The following conditions are Excludes1 from E29 (including E29.8):

• E34.5- – Androgen insensitivity syndrome
• N46.0-N46.1 – Azoospermia or oligospermia NOS
• E23.0 – Isolated gonadotropin deficiency
• Q98.0 – Klinefelter syndrome karyotype 47, XXY
• Q98.1 – Klinefelter syndrome, male with more than two X chromosomes
• Q98.4 – Klinefelter syndrome, unspecified

Klinefelter syndrome is the exclusion coders encounter most often. It is a chromosomal condition (Classified under Q codes) rather than a primary endocrine disorder, so submitting E29.8 alongside any Q98.0, Q98.1, or Q98.4 code on the same claim will generate an automatic Excludes1 denial.

The chromosomal diagnosis takes precedence in coding hierarchy when Klinefelter syndrome is documented. Additional endocrine manifestations such as hypogonadism in a Klinefelter patient are captured via the Q98.x code rather than E29.x.

There are no Excludes2 notes specific to E29.8, meaning many secondary diagnoses (such as infertility, erectile dysfunction, or metabolic conditions) can be coded alongside E29.8 when clinically documented and separately managed. Review the CDC/NCHS ICD-10-CM web tool to confirm any secondary code combination before submission.

For practices using claims management software with built-in edit checks, an Excludes1 conflict will surface before submission rather than after, preventing the denial cycle entirely. Automated coding validation at the point of claim creation is the most reliable way to catch these errors before they reach the payer.

MS-DRG groupings and reimbursement context for E29.8

E29.8 groups into the endocrine-disorder MS-DRGs for inpatient reimbursement purposes. The code is not on the CMS Present on Admission (POA) exempt list, so when E29.8 appears on an inpatient claim, providers must report a POA indicator alongside it. Accurate medical billing workflows capture that indicator at the point of documentation.

For outpatient claims, the MS-DRG assignment is not directly applicable. E29.8 functions as a supporting diagnosis code in most outpatient endocrinology encounters, pairing with the evaluation and management CPT code that reflects the complexity of the visit. The CMS Physician Fee Schedule lookup allows providers to verify reimbursement rates for the associated E/M CPT code by payer and location.

Common CPT codes used alongside E29.8 include:

• 99213-99215 – Office or other outpatient visit (Established patient), complexity-dependent
• 99202-99205 – Office or other outpatient visit (New patient)
• 80402 – Gonadal function panel (may support medical necessity documentation)
• 84402 – Testosterone, total
• 86900-series – Hormone testing panels relevant to male endocrine evaluation

Practices managing hormone and endocrine patients benefit from functional medicine practice workflows that connect lab ordering, result review, and coding in a single patient record, so what a clinician observes reaches the coder in full at billing time.

Documentation requirements for ICD-10 code E29.8

Accurate E29.8 documentation requires the provider’s clinical note to establish three things: That a testicular endocrine dysfunction is present, that it is neither hyperfunction nor hypofunction, and that a chromosomal condition (Klinefelter) has been ruled out or is not the primary diagnosis.

Without all three elements in the note, coders may default to E29.9 (Unspecified), which is technically defensible but clinically suboptimal. Clinical notes for this code should include:

• Confirmed male patient (Sex-edit compliance)
• Clinical impression naming the specific dysfunction (e.g., Mullerian inhibiting factor deficiency, or other specified testicular endocrine disorder)
• Relevant laboratory findings (AMH levels, LH, FSH, testosterone panel as applicable)
• Differential diagnosis note distinguishing the condition from hypogonadism (E29.1) or chromosomal causes
• Treatment plan or clinical management rationale

Facilities with digital intake forms that capture structured endocrine history, medication lists, and lab reference ranges give coders a more complete picture at claim time. When these details flow onto the superbill, query volume drops and the revenue cycle moves faster for these encounters.

Pabau’s approach to HIPAA compliance requirements for clinical documentation includes structured templates that can be configured for endocrine specialties, ensuring the minimum required elements are captured before the encounter closes. For practices that bill Medicare and Medicaid under CMS guidelines, consistent documentation standards directly reduce audit risk.

Conclusion

Claim denials for testicular dysfunction codes are almost always preventable. E29.8 is a specific, billable code when the clinical documentation establishes an endocrine dysfunction outside the hyperfunction and hypofunction categories, and when Klinefelter syndrome has been correctly separated into the Q98.x code set.

The Excludes1 restriction is the single most common source of denials for this code family, and structured coding workflows catch these conflicts before submission. Pairing that with the right medical billing software keeps clean claims moving.

For practices managing male endocrine conditions, Pabau’s automated clinical workflows and claims management tools help teams document E29.8 encounters accurately and submit with confidence. To see how Pabau handles diagnostic coding workflows across endocrinology and men’s health specialties, book a demo.

Continue your research

Need guidance on another endocrine diagnostic code? ICD-10 code E02 walks through the billable status, excludes notes, and documentation requirements for subclinical iodine-deficiency hypothyroidism.

Coding an adrenal or pituitary presentation? ICD-10 code E24.4 covers alcohol-induced pseudo-Cushing’s syndrome, including sequencing and documentation requirements.

Looking for EHR support for private practice? EHR for private practice compares the key features that support accurate coding and claims management in independent practice settings.

Coding benign endocrine gland neoplasms? ICD-10 code D35.7 explains the billable status and documentation requirements for benign neoplasm of other specified endocrine glands.

Frequently asked questions